147 related articles for article (PubMed ID: 35831185)
1. [Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Sumitani R; Harada T; Nakamura M; Mizuguchi M; Oura M; Sogabe K; Maruhashi T; Takahashi M; Fujii S; Nakamura S; Miki H; Kagawa K; Yada M; Matsudate Y; Uehara H; Abe M
Rinsho Ketsueki; 2022; 63(6):536-543. PubMed ID: 35831185
[TBL] [Abstract][Full Text] [Related]
2. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
Slotosch CM; Hörster S; Hertl M; Schultz E
Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
[TBL] [Abstract][Full Text] [Related]
3. Low-dose radiotherapy for primary cutaneous anaplastic large-cell lymphoma while on low-dose methotrexate.
Cornejo CM; Novoa RA; Krisch RE; Kim EJ
Cutis; 2016 Oct; 98(4):253-256. PubMed ID: 27874877
[TBL] [Abstract][Full Text] [Related]
4. CD30
Sauder MB; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
[TBL] [Abstract][Full Text] [Related]
5. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.
Aoki M; Niimi Y; Takezaki S; Azuma A; Seike M; Kawana S
Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920
[TBL] [Abstract][Full Text] [Related]
6. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Vonderheid EC; Sajjadian A; Kadin ME
J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262
[TBL] [Abstract][Full Text] [Related]
8. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
[TBL] [Abstract][Full Text] [Related]
9. Low-dose Methotrexate Treatment for Solitary or Localized Primary Cutaneous Anaplastic Large Cell Lymphoma: A Long-term Follow-up Study.
Park JB; Yang MH; Kwon DI; Seong SH; Jang JY; Suh KS; Jang MS
Acta Derm Venereol; 2020 Feb; 100(4):adv00069. PubMed ID: 31996929
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
[TBL] [Abstract][Full Text] [Related]
11. A case of systemic anaplastic large cell lymphoma with 'Hodgkin-like' appearance and skin involvement mimicking lymphomatoid papulosis.
Kiniwa Y; Ide Y; Fukushima M; Asano N; Saida T
J Cutan Pathol; 2011 Jan; 38(1):38-42. PubMed ID: 20002236
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified, associated with lymphomatoid papulosis after a 9-year follow up: A case report.
Muraoka K; Fujimoto M; Iwahashi Y; Matsuzaki I; Yonei N; Murata SI; Jinnin M
J Dermatol; 2020 Jun; 47(6):641-645. PubMed ID: 32323371
[TBL] [Abstract][Full Text] [Related]
13. Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma.
Akilov OE; Pillai RK; Grandinetti LM; Kant JA; Geskin L
Arch Dermatol; 2011 Aug; 147(8):943-7. PubMed ID: 21844453
[TBL] [Abstract][Full Text] [Related]
14. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.
Miyagaki T; Inoue N; Kamijo H; Boki H; Takahashi-Shishido N; Suga H; Shimauchi T; Kiyohara E; Hirai Y; Yonekura K; Takeuchi K; Sugaya M
Br J Dermatol; 2023 Oct; 189(5):612-620. PubMed ID: 37539944
[TBL] [Abstract][Full Text] [Related]
16. Lymphomatoid papulosis: an update and review.
Martinez-Cabriales SA; Walsh S; Sade S; Shear NH
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):59-73. PubMed ID: 31494989
[TBL] [Abstract][Full Text] [Related]
17. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
18. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
Kempf W
Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous anaplastic large-cell lymphoma with 6p25.3 rearrangement exhibits a biphasic histopathologic pattern: Two case reports and literature review.
Xue YN; Wang Z; Sun JF; Chen H
J Cutan Pathol; 2021 Dec; 48(12):1463-1470. PubMed ID: 34164830
[TBL] [Abstract][Full Text] [Related]
20. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
